This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Pieces Technology settles Texas allegations over accuracy of healthcare AI products

( September 18, 2024, 21:09 GMT | Official Statement) -- MLex Summary: Pieces Technologies, a Dallas-based artificial intelligence healthcare technology company, has agreed to resolve allegations from the Texas attorney general that the company deployed its products at several Texas hospitals after making false and misleading claims about the accuracy and safety of its products. Pieces has  agreed to disclose the extent of its products’ accuracy in what Texas Attorney General Ken Paxton called a "first-of-its-kind settlement." “AI companies offering products used in high-risk settings owe it to the public and to their clients to be transparent about their risks, limitations, and appropriate use," Paxton said. "Anything short of that is irresponsible and unnecessarily puts Texans’ safety at risk." Statement and document follow below:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login